Compare MOLN & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MOLN | ANTA |
|---|---|---|
| Founded | 2004 | 2022 |
| Country | Switzerland | Singapore |
| Employees | N/A | 113 |
| Industry | | Investment Bankers/Brokers/Service |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.9M | 182.1M |
| IPO Year | 2021 | N/A |
| Metric | MOLN | ANTA |
|---|---|---|
| Price | $3.82 | $6.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $8.38 | ★ $16.17 |
| AVG Volume (30 Days) | ★ 4.0K | 2.2K |
| Earning Date | 05-12-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $21.95 |
| Revenue Next Year | $374.07 | $30.46 |
| P/E Ratio | ★ N/A | $19.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.41 | $6.00 |
| 52 Week High | $5.36 | $13.82 |
| Indicator | MOLN | ANTA |
|---|---|---|
| Relative Strength Index (RSI) | 49.92 | 39.61 |
| Support Level | $3.61 | $6.25 |
| Resistance Level | $4.49 | $9.81 |
| Average True Range (ATR) | 0.12 | 0.41 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 68.89 | 35.26 |
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.
Antalpha Platform Holding Co provides financing, technology and risk management solutions to institutional and corporate customers in the crypto asset industry. The company operates through Antalpha Prime platform in the following areas: Supply chain financing and Technology and services. Its revenue prominently consists of technology financing fees charged on the supply chain loans.